Tapewire

Nasdaq · USD

RGNX

REGENXBIO Inc.

Export transactions ↓
Tapewire entity
2211
SEC CIK
0001590877
Parsed reports
367

Last 12 months

Inside the activity.

2 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202602
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 14, 2021 Filed Jan 14, 2021 23:55 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionCommon Stock 10,372 $35.80 $371,317.60
Disclosure

SEC source: 0001562180-21-000345 · primarydocument.xml · nonDerivative · entry 4

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,360

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 14, 2021 Filed Jan 14, 2021 23:55 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionCommon Stock 1,240 $19.50 $24,180.00
Disclosure

SEC source: 0001562180-21-000345 · primarydocument.xml · nonDerivative · entry 3

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 12, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,378 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · derivative · entry 13

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 641

Underlying: Common Stock · 1,378 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F8 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 12, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
SaleCommon Stock 1,378 $49.15 $67,728.70
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 9

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,372

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F6 · price: This transaction was executed in multiple trades at prices ranging from $49.00 to $49.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionCommon Stock 1,378 $19.50 $26,871.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 8

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 12, 2021 Filed Jan 14, 2021 18:53 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 4,200 $50.01 $210,042.00
Disclosure

SEC source: 0001562180-21-000344 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,985

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 14, 2021 23:55 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,700 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-21-000345 · primarydocument.xml · derivative · entry 6

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,240

Underlying: Common Stock · 1,700 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 12, 2021 Filed Jan 14, 2021 23:55 UTC
Simpson CurranChief Oper. & Tech. Officer
SaleCommon Stock 1,700 $50.03 $85,051.00
Disclosure

SEC source: 0001562180-21-000345 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,748

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 12, 2021 Filed Jan 14, 2021 23:55 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionCommon Stock 1,700 $19.50 $33,150.00
Disclosure

SEC source: 0001562180-21-000345 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,622 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · derivative · entry 12

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,019

Underlying: Common Stock · 2,622 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F8 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 11,100 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · derivative · entry 11

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,431

Underlying: Common Stock · 7,500 shares

Expires 2026-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F7 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
SaleCommon Stock 10,122 $49.08 $496,787.76
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 7

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,372

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $49.00 to $49.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionCommon Stock 2,622 $19.50 $51,129.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 6

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 11, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionCommon Stock 7,500 $12.10 $90,750.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 5

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 08, 2021 Filed Jan 11, 2021 16:28 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 573 $48.15 $27,589.95
Disclosure

SEC source: 0001562180-21-000283 · primarydocument.xml · nonDerivative · entry 4

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,185

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: This transaction was executed in multiple trades at prices ranging from $47.98 to $48.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 11, 2021 16:28 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 2,208 $47.49 $104,857.92
Disclosure

SEC source: 0001562180-21-000283 · primarydocument.xml · nonDerivative · entry 3

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,758

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $46.92 to $47.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 11, 2021 16:28 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 2,460 $46.45 $114,267.00
Disclosure

SEC source: 0001562180-21-000283 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,966

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $45.92 to $46.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $12.10 $0.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · derivative · entry 10

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,931

Underlying: Common Stock · 10,000 shares

Expires 2026-08-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F7 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
SaleCommon Stock 1,320 $48.13 $63,531.60
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 4

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,372

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $47.87 to $48.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
SaleCommon Stock 4,062 $47.42 $192,620.04
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 3

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,692

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $46.87 to $47.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
SaleCommon Stock 4,618 $46.43 $214,413.74
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 2

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,754

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $45.86 to $46.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 08, 2021 Filed Jan 12, 2021 21:48 UTC
Christmas Patrick J.Chief Legal Officer
Exercise / conversionCommon Stock 10,000 $12.10 $121,000.00
Disclosure

SEC source: 0001562180-21-000307 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:27 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-21-000282 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,670

Underlying: Common Stock · 1,500 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:27 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 1,500 $50.01 $75,015.00
Disclosure

SEC source: 0001562180-21-000282 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,984

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.095. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:27 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 1,500 $0.85 $1,275.00
Disclosure

SEC source: 0001562180-21-000282 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,484

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 16:28 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 10,998 $50.00 $549,900.00
Disclosure

SEC source: 0001562180-21-000283 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,426

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.095. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:29 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,185 $0.00 Strike: $19.50 $0.00
Disclosure

SEC source: 0001562180-21-000284 · primarydocument.xml · derivative · entry 3

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

Underlying: Common Stock · 5,185 shares

Expires 2027-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:29 UTC
Simpson CurranChief Oper. & Tech. Officer
SaleCommon Stock 5,185 $50.01 $259,301.85
Disclosure

SEC source: 0001562180-21-000284 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,748

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 07, 2021 Filed Jan 11, 2021 21:29 UTC
Simpson CurranChief Oper. & Tech. Officer
Exercise / conversionCommon Stock 5,185 $19.50 $101,107.50
Disclosure

SEC source: 0001562180-21-000284 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:54 UTC
PAKOLA STEVEChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 49,700 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000142 · primarydocument.xml · derivative · entry 2

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,700

Underlying: Common Stock · 49,700 shares

Expires 2031-01-04

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:54 UTC
PAKOLA STEVEChief Medical Officer
GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000142 · primarydocument.xml · nonDerivative · entry 1

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,000

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 08:53 UTC
Danos OlivierChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 52,500 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000141 · primarydocument.xml · derivative · entry 4

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires 2031-01-04

F6 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 08:53 UTC
Danos OlivierChief Scientific Officer
GrantCommon Stock 11,600 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000141 · primarydocument.xml · nonDerivative · entry 3

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,043

F5 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:49 UTC
Mills Kenneth T.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 185,167 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000139 · primarydocument.xml · derivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,167

Underlying: Common Stock · 185,167 shares

Expires 2031-01-04

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:49 UTC
Mills Kenneth T.Director · President and CEO
GrantCommon Stock 40,984 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000139 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,984

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 08:56 UTC
Vasista VittalChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 56,200 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000144 · primarydocument.xml · derivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,200

Underlying: Common Stock · 56,200 shares

Expires 2031-01-04

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 08:56 UTC
Vasista VittalChief Financial Officer
GrantCommon Stock 12,400 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000144 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,424

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:55 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantStock Option (Right to Buy) · Derivative 62,300 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000143 · primarydocument.xml · derivative · entry 2

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,300

Underlying: Common Stock · 62,300 shares

Expires 2031-01-04

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:55 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantCommon Stock 13,800 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000143 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,748

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:52 UTC
Christmas Patrick J.Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 62,500 $0.00 Strike: $44.97 $0.00
Disclosure

SEC source: 0001562180-21-000140 · primarydocument.xml · derivative · entry 2

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 62,500 shares

Expires 2031-01-04

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer.

Read SEC document
January 04, 2021 Filed Jan 6, 2021 13:52 UTC
Christmas Patrick J.Chief Legal Officer
GrantCommon Stock 13,800 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000140 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,372

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer.

Read SEC document
December 28, 2020 Filed Dec 30, 2020 21:23 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-20-007506 · primarydocument.xml · derivative · entry 4

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,170

Underlying: Common Stock · 6,500 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
December 28, 2020 Filed Dec 30, 2020 21:23 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 1,853 $49.16 $91,093.48
Disclosure

SEC source: 0001562180-20-007506 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $48.87 to $49.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 28, 2020 Filed Dec 30, 2020 21:23 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 4,647 $48.47 $225,240.09
Disclosure

SEC source: 0001562180-20-007506 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,853

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $47.87 to $48.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 28, 2020 Filed Dec 30, 2020 21:23 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 6,500 $0.85 $5,525.00
Disclosure

SEC source: 0001562180-20-007506 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 247,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 24, 2020 Filed Dec 28, 2020 16:18 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 3,376 $50.00 $168,800.00
Disclosure

SEC source: 0001562180-20-007470 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,024

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 23, 2020 Filed Dec 28, 2020 21:17 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,500 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-20-007469 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,670

Underlying: Common Stock · 4,500 shares

Expires 2024-09-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 708,200 shares, became exercisable as follows: 474,490 of the shares subject to the option are initial shares ("Initial Shares") and 233,710 of the shares subject to the option are contingent shares ("Contingent Shares"). 120,394 of the Initial Shares vested on September 17, 2014, 88,524 of the Initial Shares vested on September 17, 2015 and an additional 7,377 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

Read SEC document
December 23, 2020 Filed Dec 28, 2020 21:17 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 4,500 $50.00 $225,000.00
Disclosure

SEC source: 0001562180-20-007469 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,000

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 23, 2020 Filed Dec 28, 2020 21:17 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 4,500 $0.85 $3,825.00
Disclosure

SEC source: 0001562180-20-007469 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 23, 2020 Filed Dec 28, 2020 16:18 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 21,124 $50.01 $1,056,411.24
Disclosure

SEC source: 0001562180-20-007470 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,400

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.